BIG
ASND icon

Brookwood Investment Group’s Ascendis Pharma A/S ASND Stock Holding History

Brookwood Investment Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$852K Buy
3,194
+230
+8% +$53.7K 0.1% 204
2026
Q1 		$678K Buy
+2,964
New +$664K 0.08% 226

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Brookwood Investment Group's ASND Position: Q2 2026 in Review

Brookwood Investment Group increased its Ascendis Pharma A/S (ASND) stake by 7.8% in Q2 2026, buying an estimated $53.7K and bringing the position to 3,194 shares worth $852K. The position accounts for 0.1% of the portfolio, ranked #204.

Brookwood Investment Group first reported a position in ASND in Q1 2026 and has held it in 2 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Brookwood Investment Group held 3,194 shares of Ascendis Pharma A/S worth $852K as of Q2 2026.
  • Brookwood Investment Group bought 230 Ascendis Pharma A/S shares in Q2 2026, an estimated $53.7K.
  • Ascendis Pharma A/S made up 0.1% of Brookwood Investment Group's portfolio in Q2 2026, its #204 holding.
  • Brookwood Investment Group first reported a position in Ascendis Pharma A/S in Q1 2026 and has held it in 2 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.